New unusual side effect of weight-loss drugs becoming more common, research suggests GLP-1 drugs may interfere with medical imaging, leading to unnecessary tests, researchers have found Bookmark CommentsGo to comments A new unusual side effect of weight-loss drugs is becoming more common, research has suggested
They identified a significant association between tirzepatide use and both a lower risk of POAG and OHT, as well as initiation of glaucoma treatments in patients with type 2 diabetes, compared to those treated with selective GLP-1 drugs
doi:10.1016/j.cccn.2003.10.028 P.S
They offer so much to help you feel better and recover
Research area Semax and Selank are short peptides from Russian neuropeptide research
While it is true that a provider might switch a patient from one to the other depending on availability and medical need, this transition must be done under strict clinical supervision